| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.41 | 0.04 |